Mesenchymal stromal cell-derived extracellular vesicles for bone regeneration therapy

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cell Biology

Background:

• Mesenchymal stromal cells (MSCs) are crucial for bone regeneration.
• Extracellular vesicles (EVs) derived from MSCs are emerging as cell-free therapeutic agents.
• Understanding the mechanisms of MSC-EVs in bone repair is essential for clinical application.

Purpose of the Study:

• To review preclinical studies on MSC-derived EVs for bone regeneration.
• To identify commonalities in EV biomarker expression, miRNA cargo, and pathway activation.
• To elucidate the therapeutic mechanisms of MSC-EVs in bone regeneration.

Main Methods:

• Systematic review of preclinical studies involving MSC-derived EVs in bone regeneration.
• Analysis of EV characterization data, including biomarker expression and miRNA cargo.
• Evaluation of reported mechanisms of MSC-EV action.

Main Results:

• MSCs-EVs demonstrated efficacy in inducing bone formation across various preclinical models.
• A significant number of studies lacked comprehensive EV characterization.
• Diverse miRNA cargo profiles were observed, even within EVs from similar sources.
• Limited research has explored the underlying mechanisms of MSC-EV therapeutic effects.

Conclusions:

• There is a critical need for mechanistic preclinical studies with thorough EV characterization.
• Identifying optimal MSC-EV sources for bone regeneration requires further investigation.
• Addressing challenges in EV delivery, scalable production, and storage is vital for clinical translation.